-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $271

Benzinga·07/24/2026 15:18:01
Listen to the news
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $240 to $271.